Published online before print December 28, 2007

This Article Full Text (Rapid PDF) All Versions of this Article: jmoldx.2008.070073v1 10/1/43    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tassone, F. Articles by Hagerman, P. J. Search for Related Content PubMed PubMed Citation Articles by Tassone, F. Articles by Hagerman, P. J.

Copyright © 2008 American Society for Investigative Pathology
Journal of Molecular Diagnostics, doi:10.2353/jmoldx.2008.070073

Accepted for publication September 19, 2007.

Article

A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk Populations

Flora Tassone^*@, Ruiqin Pan^*, Khaled Amiri, Annette K. Taylor, and Paul J. Hagerman^*

From Department of Biochemistry and Molecular Medicine * and M.I.N.D. Institute, University of California, Davis, School of Medicine, Davis, California; Department of Biology, College of Sciences, United Arab Emirates University, United Arab Emirates; and Kimball Genetics, Denver, Colorado

^@ To whom correspondence should be addressed. E-mail: ftassone{at}ucdavis.edu.

	Abstract

Fragile X syndrome, the most common inherited cause of intellectual impairment and the most common single gene associated with autism, generally occurs for fragile X mental retardation 1 (FMR1) alleles that exceed 200 CGG repeats (full-mutation range). Currently, there are no unbiased estimates of the number of full-mutation FMR1 alleles in the general population; a major obstacle is the lack of an effective screening tool for expanded FMR1 alleles in large populations. We have developed a rapid polymerase chain reaction (PCR)-based screening tool for expanded FMR1 alleles. The method utilizes a chimeric PCR primer that targets randomly within the expanded CGG region, such that the presence of a broad distribution of PCR products represents a positive result for an expanded allele. The method is applicable for screening both males and females and for allele sizes throughout the premutation (55 to 200 CGG repeats) and full-mutation ranges. Furthermore, the method is capable of rapid detection of expanded alleles using as little as 1% of the DNA from a single dried blood spot. The methodology presented in this work is suitable for screening large populations of newborn or those at high risk (eg, autism, premature ovarian failure, ataxia, dementia) for expanded FMR1 alleles. The test described herein costs less than $5 per sample for materials; with suitable scale-up and automation, the cost should approach $1 per sample.

This article has been cited by other articles:

				P. J Hagerman The fragile X prevalence paradox J. Med. Genet., August 1, 2008; 45(8): 498 - 499. [Full Text] [PDF]